conflict of interest

From Aaushi
Jump to navigation Jump to search

Management

  • forego gifts from pharmaceutical, medical device & biotechnology companies
  • accept only payment at fair market value for legitimate service
  • do not make educational presentations or publish scientific articles that are controlled by industry
  • do not meet with pharmaceutical or medical device sales representatives except by appointment at a physician's request
  • do not accept drug samples except in certain situations for patients who lack financial access to medications

Notes

Additional terms

References

  1. Geriatric Review Syllabus, 8th edition (GRS8) Durso SC and Sullivan GN (eds) American Geriatrics Society, 2013
  2. Rockey SJ, Collins FS. Managing financial conflict of interest in biomedical research. JAMA. 2010 Jun 16;303(23):2400-2 PMID: https://www.ncbi.nlm.nih.gov/pubmed/20498237
  3. Medical Knowledge Self Assessment Program (MKSAP) 11, 17. American College of Physicians, Philadelphia 1998, 2015
  4. Brennan TA, Rothman DJ, Blank L et al Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. JAMA. 2006 Jan 25;295(4):429-33. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16434633
  5. 5.0 5.1 Yancy CW, Harrington RA, Bonow RO. Author Relationships With Industry. Policies and Procedures for Authors and Editors of JAMA Cardiology JAMA Cardiol. Published online September 27, 2017 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28973086 <Internet> http://jamanetwork.com/journals/jamacardiology/article-abstract/2654954
  6. 6.0 6.1 OpenPaymentsData.CMS.gov https://openpaymentsdata.cms.gov/